APGE
Price
$37.57
Change
+$0.73 (+1.98%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
2.2B
62 days until earnings call
PROK
Price
$2.52
Change
-$0.09 (-3.44%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
353.68M
62 days until earnings call
Interact to see
Advertisement

APGE vs PROK

Header iconAPGE vs PROK Comparison
Open Charts APGE vs PROKBanner chart's image
Apogee Therapeutics
Price$37.57
Change+$0.73 (+1.98%)
Volume$6.95K
Capitalization2.2B
ProKidney
Price$2.52
Change-$0.09 (-3.44%)
Volume$13.26K
Capitalization353.68M
APGE vs PROK Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. PROK commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (APGE: $36.84 vs. PROK: $2.62)
Brand notoriety: APGE and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 61% vs. PROK: 28%
Market capitalization -- APGE: $2.2B vs. PROK: $330.73M
APGE [@Biotechnology] is valued at $2.2B. PROK’s [@Biotechnology] market capitalization is $330.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 1 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 1 bullish, 6 bearish.
  • PROK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PROK is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -4.21% price change this week, while PROK (@Biotechnology) price change was +18.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was +5.87%, and the average quarterly price growth was +34.62%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.2B) has a higher market cap than PROK($354M). PROK YTD gains are higher at: 49.408 vs. APGE (-17.064). PROK has higher annual earnings (EBITDA): -157.52M vs. APGE (-270.1M). APGE has more cash in the bank: 505M vs. PROK (295M). PROK has less debt than APGE: PROK (4.42M) vs APGE (10.8M). PROK has higher revenues than APGE: PROK (527K) vs APGE (0).
APGEPROKAPGE / PROK
Capitalization2.2B354M620%
EBITDA-270.1M-157.52M171%
Gain YTD-17.06449.408-35%
P/E RatioN/AN/A-
Revenue0527K-
Total Cash505M295M171%
Total Debt10.8M4.42M244%
TECHNICAL ANALYSIS
Technical Analysis
APGEPROK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 21 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOXF0.13N/A
+1.96%
QUANTUM CRITICAL METALS CORP.
ELUXY11.600.10
+0.91%
AB Electrolux
IBIDF43.00N/A
N/A
Ibiden Co. Ltd.
SMNEY108.63-3.40
-3.03%
Siemens Energy AG
XTPT0.50-0.06
-10.43%
Xtra Energy Corp.

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.98%
SYRE - APGE
54%
Loosely correlated
+1.82%
CRNX - APGE
51%
Loosely correlated
+0.29%
DYN - APGE
49%
Loosely correlated
+1.35%
XNCR - APGE
47%
Loosely correlated
+7.31%
ELVN - APGE
47%
Loosely correlated
+3.17%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-3.63%
RLYB - PROK
44%
Loosely correlated
-5.17%
NRIX - PROK
39%
Loosely correlated
+1.54%
APGE - PROK
38%
Loosely correlated
+1.98%
KYMR - PROK
37%
Loosely correlated
-1.35%
ZYME - PROK
37%
Loosely correlated
+0.25%
More